Breaking into the Mainstream: The Rise of ESG in Business Management
Asian Business Research Journal · 30.06.2025 · 10 (6) · 28-36
DOI: 10.55220/25766759.482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Business Research Journal, online erschienen am 30.06.2025. Verfasst von Md. Khalilur Rhaman und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The concept of Environmental, Social, and Governance (ESG) has a rich and multifaceted history. However, a clear chronological evolution linking key historical events to the modern framework of ESG in business management remains underexplored. This study aims to establish a structured timeline that traces the development of ESG in business management through a review of existing literature and pivotal historical influences. Findings indicate that ESG originated from Corporate Social Responsibility (CSR), Socially Responsible Investment (SRI), and broader societal ethical expectations. Major historical events, such as the Vietnam War, civil rights movements, environmental activism, and initiatives like the United Nations Global Compact, have significantly shaped today’s ESG principles in business management. The study highlights the most impactful events and trends that contributed to ESG’s current conceptual form.
Zitieren
APA
Rhaman, M. K., Haque, M., & Darda, M. A. (2025). Breaking into the Mainstream: The Rise of ESG in Business Management. Asian Business Research Journal, 10(6), 28-36. https://doi.org/10.55220/25766759.482
Vancouver
Rhaman MK, Haque M, Darda MA. Breaking into the Mainstream: The Rise of ESG in Business Management. Asian Business Research Journal. 2025;10(6):28-36. doi:10.55220/25766759.482
BibTeX
@article{Rhaman2025,
author = {Rhaman, Md. Khalilur and Haque, Mahfuzul and Darda, Md. Abud},
title = {Breaking into the Mainstream: The Rise of ESG in Business Management},
journal = {Asian Business Research Journal},
year = {2025},
volume = {10},
number = {6},
pages = {28--36},
doi = {10.55220/25766759.482}
}
EUVIMED